Polypharmacy and Mild Cognitive Impairment in Older Adults: A 3-year Study of DO-HEALTH
Journal of the American Medical Directors Association · 2025
DOI: 10.1016/j.jamda.2025.105586 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Medical Directors Association, 2025. Verfasst von Caroline de Godoi Rezende Costa Molino und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre on Aging and Mobility, University of Zurich, Zurich, Switzerland; Department of Geriatrics and Aging Research, University of Zurich, Zurich, S…. Hauptthemen laut MEDLINE: Polypharmacy, Cognitive Dysfunction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: F Hoffmann-La Roche Ltd, Pfizer, European Commission Seventh Framework Programme for Research and Technological Development Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre on Aging and Mobility, University of Zurich, Zurich, Switzerland; Department of Geriatrics and Aging Research, University of Zurich, Zurich, Switzerland.
- Department of Geriatrics and Aging Research, University of Zurich, Zurich, Switzerland; University Clinic for Aging Medicine, Zurich City Hospital, Zurich, Switzerland.
- Centre on Aging and Mobility, University of Zurich, Zurich, Switzerland; Department of Geriatrics and Aging Research, University of Zurich, Zurich, Switzerland; University Clinic for Aging Medicine, Zurich City Hospital…
- Department of Aging Medicine, Felix Platter, University of Basel, Basel, Switzerland.
Förderung
- F Hoffmann-La Roche Ltd
- Pfizer
- European Commission Seventh Framework Programme for Research and Technological Development Health
- DSM Nutritional Products AG
- Nestec SA
Zitieren
APA
de Godoi Rezende Costa Molino, C., Baumann, K., Gaengler, S., Meyer-Heim, T., Sadlon, A., Freystaetter, G., Kressig, R. W., Egli, A., & Bischoff-Ferrari, H. A. (2025). Polypharmacy and Mild Cognitive Impairment in Older Adults: A 3-year Study of DO-HEALTH. Journal of the American Medical Directors Association. https://doi.org/10.1016/j.jamda.2025.105586
Vancouver
de Godoi Rezende Costa Molino C, Baumann K, Gaengler S, Meyer-Heim T, Sadlon A, Freystaetter G, et al. Polypharmacy and Mild Cognitive Impairment in Older Adults: A 3-year Study of DO-HEALTH. Journal of the American Medical Directors Association. 2025. doi:10.1016/j.jamda.2025.105586
BibTeX
@article{deGodoiRezendeCostaMolino2025,
author = {de Godoi Rezende Costa Molino, Caroline and Baumann, Konstantin and Gaengler, Stephanie and Meyer-Heim, Tatjana and Sadlon, Angélique and Freystaetter, Gregor and Kressig, Reto W and Egli, Andreas and Bischoff-Ferrari, Heike A},
title = {Polypharmacy and Mild Cognitive Impairment in Older Adults: A 3-year Study of DO-HEALTH},
journal = {Journal of the American Medical Directors Association},
year = {2025},
doi = {10.1016/j.jamda.2025.105586}
}
EUVIMED